Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MET | TEL |
|---|---|---|
| Price | $97.84 | $213.88 |
| Change today | ▲ 0.66% | ▼ 0.24% |
| Market cap | $62.18B | $61.92B |
| Return, 3 months | +16.4% | +8.1% |
| Return, year to date | +26.6% | -5.0% |
| Return, 1 year | +24.8% | +0.6% |
| P/E (TTM) | 18.7 | 20.9 |
| P/B | 2.3 | 4.7 |
| P/E percentile vs own 5y | 64th | 58th |
| Dividend yield | 2.35% | 1.36% |
| Revenue growth (YoY, latest qtr) | +9.9% | +13.8% |
| Net profit growth (YoY) | +6.0% | +17.2% |
| Gross margin | – | 36.1% |
| Operating margin | – | 20.5% |
| Net margin | 4.4% | 15.6% |
| Return on equity | 12.5% | 23.5% |
| Analyst target vs. price | +8.4% | +17.4% |
| Analyst buy share | 91% | 70% |
| RSI (14) | 53 | 57 |
| 30-day volatility | 19.0% | 32.4% |
| Max drawdown, 1 year | -17.5% | -20.8% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.